Constellation Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 29.587 million compared to USD 20.841 million a year ago. Net loss was USD 29.753 million compared to USD 20.767 million a year ago. Basic loss per share from continuing operations was USD 0.7 compared to USD 0.8 a year ago. For the half year, operating loss was USD 55.570 million compared to USD 40.947 million a year ago. Net loss was USD 55.197 million compared to USD 40.193 million a year ago. Basic loss per share from continuing operations was USD 1.31 compared to USD 1.56 a year ago.